State Street Corp Orgenesis Inc. Transaction History

State Street Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.39 - $0.63 $4,375 - $7,067	11,219 Added 16.58%	78,878 $47,000
Q1 2024 May 15, 2024	SELL	$0.28 - $0.9 $5,880 - $18,900	-21,000 Reduced 23.69%	67,659 $55,000
Q1 2022 May 16, 2022	BUY	$2.31 - $3.72 $14,227 - $22,911	6,159 Added 7.47%	88,659 $308,000
Q2 2021 Aug 16, 2021	SELL	$4.19 - $5.88 $850,322 - $1.19 Million	-202,941 Reduced 71.1%	82,500 $418,000
Q1 2021 May 17, 2021	BUY	$4.77 - $8.08 $69,680 - $118,032	14,608 Added 5.39%	285,441 $1.64 Million
Q4 2020 Feb 16, 2021	BUY	$4.4 - $5.63 $157,326 - $201,306	35,756 Added 15.21%	270,833 $1.22 Million
Q3 2020 Nov 10, 2020	SELL	$4.75 - $5.99 $19,570 - $24,678	-4,120 Reduced 1.72%	235,077 $1.19 Million
Q2 2020 Aug 14, 2020	BUY	$3.6 - $7.84 $861,109 - $1.88 Million	239,197 New	239,197 $1.45 Million

134K

Ticker ORGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,545,800
Market Cap $23M
Description
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.